An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus E ...
A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumab in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumab in Combination Wit ...